Psychemedics Corporation (PMD)
NASDAQ: PMD · Real-Time Price · USD
2.332
+0.002 (0.07%)
Nov 21, 2024, 11:46 AM EST - Market open
Psychemedics Revenue
Psychemedics had revenue of $5.18M in the quarter ending September 30, 2024, a decrease of -9.27%. This brings the company's revenue in the last twelve months to $20.26M, down -11.16% year-over-year. In the year 2023, Psychemedics had annual revenue of $22.10M, down -12.45%.
Revenue (ttm)
$20.26M
Revenue Growth
-11.16%
P/S Ratio
0.67
Revenue / Employee
$174,638
Employees
116
Market Cap
13.74M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.10M | -3.14M | -12.45% |
Dec 31, 2022 | 25.24M | 331.00K | 1.33% |
Dec 31, 2021 | 24.91M | 3.55M | 16.62% |
Dec 31, 2020 | 21.36M | -16.32M | -43.31% |
Dec 31, 2019 | 37.68M | -5.00M | -11.71% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cumberland Pharmaceuticals | 36.79M |
STRATA Skin Sciences | 32.68M |
Vivos Therapeutics | 14.58M |
Can-Fite BioPharma | 667.00K |
Traws Pharma | 226.00K |
PMD News
- 8 days ago - Psychemedics Corporation Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing - GlobeNewsWire
- 3 months ago - Psychemedics Corporation Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Psychemedics Corporation's Board of Directors Approves Plan to Terminate Registration of Its Common Stock - GlobeNewsWire
- 5 months ago - Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing - GlobeNewsWire
- 6 months ago - Psychemedics Corporation Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - Psychemedics Corporation Reports 2023 Financial Results - GlobeNewsWire
- 8 months ago - Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider - GlobeNewsWire